Caprine arthritis encephalitis virus (CAEV) is the natural lentivirus of goats, well known for its tropism for macrophages and its inability to cause infection in lymphocytes. The viral genome lacks nef, tat, vpu and vpx coding sequences. To test the hypothesis that when nef is expressed by the viral genome, the virus became toxic for lymphocytes during replication in macrophages, we inserted the SIVsmm PBj14 nef coding sequences into the genome of CAEV thereby generating CAEV-nef. This recombinant virus is not infectious for lymphocytes but is fully replication competent in goat macrophages in which it constitutively expresses the SIV Nef. We found that goat lymphocytes cocultured with CAEV-nef-infected macrophages became activated, showing increased expression of the interleukin-2 receptor (IL-2R). Activation correlated with increased proliferation of the cells. Interestingly, a dual effect in terms of apoptosis regulation was observed in exposed goat lymphocytes. Nef was found first to induce a protection of lymphocytes from apoptosis during the first few days following exposure to infected macrophages, but later it induced increased apoptosis in the activated lymphocytes. This new recombinant virus provides a model to study the functions of Nef in the context of infection of macrophages, but in absence of infection of T lymphocytes and brings new insights into the biological effects of Nef on lymphocytes.
Introduction
CAEV is the natural lentivirus of goats that causes persistent infections in goats all over the world. CAEV was first isolated from the joint of an arthritic goat and simultaneously from the brain of an encephalitic kid (Crawford et al., 1980; Narayan et al., 1980) . The virus genome was cloned, fully sequenced and the genes coding the viral proteins characterized (Saltarelli et al., 1990 (Saltarelli et al., , 1994 . CAEV of goats like-Maedi Visna virus of sheep are lentivirus genus members that have a simple genome that contains only 2 additional regulatory and one accessory genes in addition to the prototypic retroviral gag, pol and env genes (Villet et al., 2003a (Villet et al., , 2003b Staskus et al., 1991) . Among retroviruses, the primate lentiviruses HIV and SIV have a remarkably complex genome containing in addition to the retroviral genes, several additional open reading frames that encode three regulatory (Vif, Tat and Rev) and four accessory proteins (Nef, Vpu, Vpr and Vpx) that play important roles in pathogenesis of the infection with these viruses. One of the characteristics of primate lentivirus infection is the progressive depletion of CD4+ T cells that leads to the development of AIDS. Nef is well known to be one of the key factors thought to be involved in this process of causing dysfunction and death of CD4+ T cells (Muthumani et al., 2005; Priceputu et al., 2005; Lelievre et al., 2004; Alimonti et al., 2003) .
Nef is a 27-to 35-kDa myristylated protein that is expressed early during the viral life cycle in the cell, but it does not become incorporated into virus particles. Although the precise functions of this protein are not fully understood, the results of studies in rhesus macaques demonstrated that Nef plays a crucial role for the maintenance of high viral loads and subsequent development of SIV-specific pathogenesis (Kestler et al., 1991; Beer et al., 1997) . Studies in the in SCID-hu mouse model confirmed the requirement of Nef for maintenance of high virus loads of HIV-1 (Gulizia et al., 1997; Aldrovandi et al., 1998; Aldrovandi and Zack, 1996) . As a corollary, structural studies of the HIV-1 genome revealed that some long-term survivors of AIDS in patients infected with HIV-1 are associated with infection with Nef-defective HIV-1 (Deacon et al., 1995; Rhodes et al., 2000) .
Several studies have shown that the productive phase of replication of HIV is dependent on the ability of Nef to induce the activation of latently infected cells (Fujinaga et al., 1995; Alexander et al., 1997) . Indeed, it has been shown that Nef perturbs cell activation pathways, thereby influencing viral replication in host (Skowronski et al., 1993; Quaranta et al., 1999) . HIV-1 Nef was also shown to interfere with numerous kinase phosphorylation pathways inducing cell activation and extracellular signaling (Blagoveshchenskaya et al., 2002; He et al., 2004; Suzu et al., 2005; Lee et al., 2005; Fenard et al., 2005; Mann et al., 2005; Wei et al., 2005) .
SIVsmm PBj14 is a unique strain of SIV which was isolated from a pig-tailed macaque (Macaca nemestrina) PBj at the time of its death, 14 months after inoculation with SIVsmm9 (Fultz, 1989) . SIVsmm PBj14 differs from other primate lentiviruses in that, it induces a hyperacute disease syndrome which is marked by a rapid induction of T cell activation and proliferation, particularly in gut-associated lymphoid tissues ending with death of pig-tailed and cynomologus macaques and sooty mongabeys (Fultz, 1989) within 6-10 days following virus inoculation. The acute pathogenic effects of this virus appeared to be associated with at least two in vitro characteristics: the ability of the virus to induce lymphocyte activation and proliferation and also to replicate in resting mononuclear cells in which the CD4+ T cells become activated following infection with the virus (Fultz and Zack, 1994; Thai and Fultz, 1998; Rosenberg et al., 1991) . Earlier data established that the protein encoded by the nef gene of SIVsmm PBj14 were directly responsible for the activation of resting PBMC. However, the mechanism of this Nef-dependent process still remains poorly characterized because subsequent replication of the virus in the cells caused their death. Two amino acids in Nef PBj14 (aa 17 tyrosine and aa 18 glutamic acid) were shown to be strongly linked to this process of lymphocyte activation (Saucier et al., 1998; Dehghani et al., 2002b) . Whether these activated lymphocytes are massively killed by the virus infection or by apoptotic death that results from the activation cascade process is not well established.
The implication of SIV and HIV Nef in apoptosis regulation has already been suggested. Recent studies have shown that HIV-1 Nef protects infected cells from apoptosis (Yoon et al., 2001; Geleziunas et al., 2001) . A functional interaction between Nef and the cellular protein ASK1, known as an inhibitor of anti-apoptotic factors, induces the anti-apoptotic activity via Bcl2 and Bcl-XL. Such interaction demonstrated that Nef was implicated in the regulation of the apoptosis process. In contrast, Nef has been described as a strong apoptosis inducer both in vitro and in vivo (Johnson, 1997; Rasola et al., 2001; Zauli et al., 1999) via the activation of Fas/Fas-ligand pathway. Indeed, in HIV-1 and SIV infections, Fas and FasL have been shown to be upregulated in CD4+ and CD8+ T cells of HIV-1-infected patients or SIV-infected macaques and in cultured human T cells following their infection with HIV-1. Further, these lymphocytes were shown to have increased susceptibility to Fasmediated killing (Blagoveshchenskaya et al., 2002) . This mechanism of induction of apoptotic cell death of CD4+ and CD8+ T cells by HIV-1 or SIV via activation of FasL or Fas expression was found to be dependent on a functional Nef protein (Yoon et al., 2001; Johnson, 1997) and involves p38 mitogen-activated protein kinase (Muthumani et al., 2005) . In addition, the upregulation of FasL on HIV-1-infected macrophages has been reported to mediate the apoptosis of uninfected T cells (Okada et al., 1997a (Okada et al., , 1997b (Okada et al., , 1998 . HIV-1 Nef was shown to promote phenotypic and functional differentiation of dendritic cells that induce activation of T lymphocytes (Quaranta et al., 2002) . Recently it was reported that HIV Nef induces suppression of CD40-dependent immunoglobulin class switching in bystander B cells (Qiao et al., 2006) . However, despite these observations, a clear demonstration of the action of Nef in bystander non-infected T cells has never been unequivocally proven because death of cells from infection could not be disproved.
In the experiments reported here, we examined whether SIVsmm PBj14 Nef could induce biological modifications on bystander lymphocytes when cocultivated with monocyte derived macrophages (MDMs) expressing the Nef. We developed a lentiviral model, based on the genome of the caprine arthritis encephalitis virus (CAEV). CAEV is a prototypic lentivirus closely related to the primate lentiviruses HIV and SIV, but in contrast to these viruses CAEV lacks nef, vpu, vpr and vpx accessory genes (Narayan et al., 1982 (Narayan et al., , 1983 . The virus replicated productively in macropahges but does not infect CD4+ T cells nor does it induce AIDS in infected goats.
We generated a chimeric virus called CAEV-nef that carries the coding sequences of SIVsmm pBJ14 nef in addition of all coding sequences of CAEV. This virus was shown to be infectious, replication competent in goat MDMs, and in goat synovial membrane cells (GSMs) and to constitutively express SIV Nef in infected cells. Coculture of goat MDMs infected with CAEV-nef with goat PBMCs showed overexpression of IL-2R at the surface of goat lymphocytes, a marker of activation that was correlated with increased proliferation of the cells. Kinetic studies on the cocultivated PBMCs showed that the cells exposed to goat MDMs expressing Nef were first protected from apoptotic cell death in the early stage of exposure and then succumbed to apoptosis later. PCR examination of cocultured PBMCs revealed lack of infection in these cells.
Results

CAEV-nef chimeric virus is infectious and replication competent
The genomic organization of the CAEV-nef recombinant virus and the parental CAEV is shown in Fig. 1 . The full-length infectious molecularly cloned genome derived from the CO strain of CAEV, named CAEV (Fig. 1b) , was used as a vector to insert the coding sequences for Nef isolated from the genome of SIV-PBj14 (Fig. 1a) as described in Materials and methods (Fig. 1c) . To produce virus stocks from both genomes, plasmid DNAs were transfected into semi confluent monolayers of GSM cells and supernatant fluids collected 5 days later were titrated in GSM cells and used to inoculate fresh GSM cells at MOI = 0.1 for virus stock production. Titers of virus stocks were harvested on days 3, 5 and 7 post-inoculation in GSM cells that measured 10 4 , 10 5.5
and 10 6 TCID 50/ml for CAEV and 10 4.5 , 10 6 and 10 7 TCID 50/ml for CAEV-nef, respectively. These data showed that CAEV-nef replicated with a slightly higher efficiency than parental CAEV despite having a 10% increase of the size of its genome by the insertion of nef. Immunocytochemical analysis using a mouse polyclonal antibody specific to SIV Nef showed efficient Fig. 1 . Structural organization of parental CAEV, SIV and CAEV-nef chimeric genomes. SIV PBj14 nef coding sequences were amplified by PCR using specific primers as shown in panel a. The PCR product containing the end of CAEV tat, the 60 nucleotide spacer and the complete coding sequences of SIV PBj14 nef was sub-cloned into pGEMt plasmid then re-isolated following double digestion with Sma-1 and Spe-1 enzymes. This fragment was inserted into the unique Sma-1 site of CAEV (b) genome to generate CAEV-nef chimeric genome (c). The locations of primers used for PCR and expected PCR products are represented by arrows and solid bars, respectively, under each genome. Fig. 2 . Detection of SIV Nef expression by immunocytochemistry and radioimmunoprecipitation, RIPA. Non-infected (a), CAEV-infected (b) and CAEV-nef-infected (c) GSM cells were incubated successively with a primary anti-Nef mouse polyclonal antibody and a secondary biotinylated polyclonal rabbit anti-mouse Ig. Specific staining was obtained following incubation in a solution containing streptavidine-biotin-peroxidase complex. For RIPA analysis (d) CAEV-nef-infected GSM cells were incubated with 35 S-methionine and cysteine and radiolabelled protein were immunoprecipitated from the supernatant (S) and cell lysate (C) with serum from a normal non-infected goat (1) with serum from a hyperimmune goat infected with CAEV (2) that immunoprecipitated the major Gag p25 and Env gp170 and gp 135, and a rabbit polyclonal anti-Nef serum (3) that immunoprecipitates the SIV Nef p34. Proteins were separated in SDS-PAGE and autoradiographied using standard methods and commercial high molecular weight protein marker for protein size determination. expression of SIV Nef protein in the syncitia induced in infected GSM cells (Fig. 2c ). In addition, the 34-kDa Nef protein was specifically immunoprecipitated from the cell lysate of infected GSM cells (Fig. 2d) .
Monolayers of GSM cells inoculated with CAEV and CAEV-nef at MOI = 0.1 were examined at day 7 post-infection (Fig. 3) . The evaluation of induced CPE was performed by scoring the number of nuclei per syncitium in 20 randomly selected syncitium and the number of syncitium per field in 20 randomly selected microscopic fields in infected GSM cells stained by May-Grünwald-Giemsa. The data were used to determine the average values and to plot the histograms reported in Figs. 3d-e. The results showed clearly that infection with the chimeric CAEV-nef caused increased CPE characterized by higher numbers of syncitium and higher numbers of nuclei per syncitium as well.
SIV Nef induces activation of goat lymphocytes
Because IL-2 receptor expression at the surface of lymphocytes is closely related to the activated state of the cells, we kinetically measured the IL-2 R expression on goat PBMCs following their contact with non-infected, CAEV and CAEVnef-infected goat MDMs. Monolayers of goat MDMs in 6-well plates (10 5 cells/well) were inoculated with 10 4 TCID 50 of CAEV and CAEV-nef. At day 3 post-inoculation, 5 × 10 6 PBMCs freshly prepared from the same goat were cocultured in suspension with MDM monolayers. Samples of 0.5 × 10 6 cells in suspension harvested at days 2, 5, 7, 12 and 15 were stained with an antibody specific to goat IL-2 receptor and analyzed by flow cytometry. Except for the day two samples, the proportion of cells expressing IL-2R was continuously higher from day 5 to day 15 among lymphocytes cocultured with macrophages infected with CAEV-nef compared to non-infected or CAEVinfected macrophages (Fig. 4) . To ensure that goat lymphocytes were not infected with the chimeric virus when cocultured with infected MDMs, DNA was isolated from samples of cells in suspension and used for PCR analysis. DNA was isolated from infected macrophages were used as positive control. The data in Fig. 5 show clearly the successful amplification of PCR products with the expected sizes with macrophage DNA samples but not with lymphocyte DNAs in which only the 393-bp corresponding to actin product was amplified. The negative result of PCR analysis ruled out the possibility that the increased activation of PBMC seen in coculture with CAEV-nef infected MDMs was the result of direct infection of more than few of these cells.
Altogether, these data demonstrated that exposure of goat PBMCs to CAEV-nef-infected macrophages induced an increased proportion of IL-2R expressing goat lymphocytes in absence of their infection. We therefore concluded that SIV Nef induced a bystander activation of goat lymphocytes.
The activation of goat lymphocytes by SIVsmm PBj14 Nef is associated with an increased proliferation activity
Since the Nef protein of SIV PBj14 is well known for its mitogenic effects on macaque lymphocytes both in vitro and in . PCR analysis of DNA isolated from macrophage and lymphocyte cultures Goat MDMs infected with CAEV and CAEV-nef were cocultured with fresh PBMCs and 7 days later DNAs were isolated from cells in suspension and from MDM monolayers. DNA samples were examined by PCR using CAEV tat/env and SIV nef primers. Actin primers were used as internal controls to ensure the quality and quantity of DNA. The primers specific to tat and env sequences should generate an amplified fragment DNA containing 142 bp and 1226 bp from CAEV and CAEVpBSCAnef genomes respectively. The primers specific to SIV nef coding sequences amplify a PCR product of 1084 bp from CAEVpBSCAnef genome only. Actin primers generate a PCR product of 393 bp specific. Samples 1, 4, 7 and 10 are DNAs from non-infected cells, 2, 5, 8 and 11 from CAEV-infected and 3, 6, 9 and 12 from CAEV-nef-infected cells. PCR amplification was performed as described in Materials and methods, and 10 μl of aliquots from each sample was separated by electrophoresis on 1.5% agarose gel, and then DNA product was visualized by staining with ethidium bromide. vivo, we examined whether CAEV-nef had induced proliferation of lymphocytes cocultured with MDMs infected with the virus. Using the incorporation of BrdU method, we examined in parallel the proliferative activity of goat PBMCs cocultured with non-infected macrophages and CAEV-nef and CAEVinfected MDMs. In one coculture of PBMCs with non-infected macrophages, PHA and IL-2 were added to stimulate lymphocyte proliferation as positive control. Samples of 0.5 × 10 6 cells in suspension harvested at days 2, 5, 7, 10, 12 and 15 were incubated with BrdU and then stained with a specific mAb antiBrdU prior to analysis by flow cytometry. The results reported in Fig. 6 showed 5-to 6-fold higher incorporation rate of BrdU in all examined samples of lymphocytes from PBMCs that were in contact with macrophages infected with CAEV-nef. This higher rate of lymphocyte proliferation was maintained throughout the 15-day study period. These results showed that 
SIVsmm PBj14 Nef protein has a dual role on the modulation of apoptosis in goat lymphocytes
It is well known that activation of lymphocytes is followed by apoptosis of the cells reviewed in Thome and Tschopp (2001) and Tripathi and Hildeman (2004) . Since we found that the exposure of goat lymphocytes to CAEV-infected macrophages expressing of SIV Nef resulted in activation and proliferation in absence of their infection, we wanted to determine whether these activated proliferating lymphocytes developed accelerated onset of apoptosis using the coculture model described above. As positive control, a coculture of PBMCs with non-infected macrophages was treated with staurosporine. During the first 7 days of coculture, the proportion of apoptotic lymphocytes following exposure to CAEVnef-infected macophages was found to be 2-fold (15%) less than that observed with lymphocytes exposed to non-infected (29%) or CAEV-infected (34%) macrophages, while the staurospaurine treated cells showed 50% of apoptotic cells (Fig. 7) . In contrast, at day 12 of coculture, increased apoptosis of lymphocytes (63%) was observed with those exposed to CAEV-nefinfected MDMs, which was close to the proportion obtained with the staurosporine-treated cells (75%), while lymphocytes exposed to CAEV-infected and to non-infected macrophages showed lower percentages of apoptotic cells (46% and 37% respectively). Interestingly, the low apoptosis associated with SIV Nef in goat lymphocytes coincided with the lack of activation of the cells (before day 9 post-coculture) whereas increased SIV Nef-induced apoptosis in lymphocytes coincided with the period when they were activated and in a proliferative state (day 12 post-coculture).
Discussion
Recently we described a new lentiviral model to study the function of primate lentivirus accessory genes in the context of virus infection/replication in MDMs, but in absence of infection of CD4+ T cells (Bouzar et al., 2003 (Bouzar et al., , 2004 . Using this model, we report here the development of a new chimeric virus expressing the nef gene of the SIVsmm PBj14 by the infectious genome of CAEV. SIV PBj nef was chosen to illustrate the proof of the concept because of its well-known abilities to induce a high level of activation and proliferation of T cells both in cultures and in animals. Since our aim was to examine whether there is an effect in a non-natural host of SIV, we hypothesized that the SIV PBj nef was the best choice to induce Fig. 7 . Analysis of induced apoptosis in bystander goat lymphocytes. Analysis of apoptosis was performed on goat lymphocytes in PBMCs cocultured with MDMs infected with CAEV and CAEV-nef. Non-treated PBMCs cocultured with non-infected MDMs and those treated with staurosporin were used as negative and positive controls, respectively. Samples were examined at days 7 and 12 and the proportion of lymphocytes that underwent apoptosis was determined following evaluation of the rate of DNA breaks with apostain and examination by flow cytometry. The percentage of apoptotic lymphocytes was determined by gating cells according to their forward-scatter versus side-scatter characteristics and then measuring the percentage of those cells that were FITC positive (Apostain). The specificity of this antibody was examined normal (nor) PBMCs and PBMCs treated with staurosporin (ST) and examples of histograms are shown in the top of the figure. measurable effects on goat lymphocytes. The resulting CAEVnef virus is still strictly macrophage tropic and could not infect T cells. These cells nevertheless became activated and underwent proliferation and apoptosis when exposed to infected macrophages expressing Nef.
The chimeric genome CAEV-nef was generated by the insertion of 1 kb sequences of SIV Nef in the 9-kb genome of CAEV. Despite 10% increase of genome, the resulting chimeric virus was fully replication competent with titer at least as high as that of the parental virus and efficiently expressed the transgene. Interestingly, following 10 serial passages of CAEVnef in GSM cells the expression of the transgene was still detected in infected cells (data not shown). Immunoprecipitation and PCR analysis confirmed that the SIV nef gene was correctly inserted and the Nef protein consistently expressed in the infected cells.
Several studies had shown that the ability of SIVsmm PBj14 to cause hyperacute lethal disease was strongly associated with the ability of the virus to cause activation of resting PBMCs leading to the enhancement of virus replication. Since studies of mechanisms of PBMC activation with the SIVsmm PBj14 showed that the nef gene was directly implicated in this process (Stephens et al., 1998; Dehghani et al., 2002a; Du et al., 1995) , we were interested to determine whether this is a cis-acting mechanism affecting infected cells only or a trans-acting mechanism that affects non-infected cells as well. Data here presented are the first demonstration of cross species interaction of SIV Nef that induced mitogenic and apoptotic activities in caprine PBMCs. The activation process as observed with the increased expression of IL-2R at the surface of goat lymphocytes correlated with an increased proliferative activity following exposure to macrophages expressing SIVsmm PBj Nef. Since lymphocytes were not infected with the virus, the activation/proliferation processes could have been induced by soluble factors released by the infected macrophages or by cell associated factors expressed at the surface of infected macrophages, following contact. Since the incubation of goat lymphocytes with infectious cell-free supernatant fluid of CAEV-nef-infected macrophages did not result in increased cell activation/proliferation or apoptosis (data not shown), we concluded that these processes had been induced via cell associated factors at the surface of infected macrophages. Therefore, we concluded that the extracellular Nef that could be released by lysis of infected cells was not responsible for this process. Thus, the Nef of SIVsmm PBj14 expressed in goat macrophages had induced all three biological effects: activation, proliferation and apoptosis in the lymphocytes without causing infection in the latter. The results of apoptosis induced in lymphocytes exposed to Nef-expressing infected MDMs showed different effects at 7 and 12 days post-exposure. Indeed, at 7 days Nef showed a protective effect of cells from undergoing apoptosis. This Nef-induced protection from apoptosis has been reported earlier and involves two mechanisms. Nef induces the protection of cells from apoptosis by interacting with the external death signal pathways mainly by the inhibition of Ask1 (Geleziunas et al., 2001 ). Nef also mediates the activation of PI3K and PAK resulting in phosphorylation of Bad, a Bcl-2 protein family, which results in increase of the anti-apoptotic Bcl-X L protein that enhances the survival of cells (Wolf et al., 2001) . Recently Nef was shown to induce protection of human-monocyte-derived macrophages from apoptosis induced by HIV-1 (Olivetta and Federico, 2006) and this protection correlated with a hyperphosphorylation of the pro-apoptotic Bad protein. In contrast, at 12 days Nef showed an enhancement of apoptotic death of lymphocytes. Nef-induced apoptotic death of infected as well as bystander cells has also been documented. Extracellular Nef has been suggested to induce apoptosis in PBMCs (Okada et al., 1997b; James et al., 2004) . However, in our experiments, the failure of the supernatant of Nef-expressing infected MDMs to induce apoptosis of PBMCs suggested either the rarity of extracellular Nef in our experimental conditions or this protein is inactive when not associated with the plasma membrane. Nef has been also shown to induce apoptosis of microvascular endothelial cells (Acheampong et al., 2005) .
The main pathway used by Nef to induce apoptosis is via increased expression of FasL in Nef-expressing cells that allows the killing of bystander T cells via Fas-FasL pathway (Xu and Screaton, 2001; Fackler and Baur, 2002; Fackler et al., 1999; Krautkramer et al., 2004) . However, the primate models in which bystanders could be infected by Nef expressing virus could not absolutely exclude the possibility that at least a proportion of bystander cells in the studies were infected. This is the first lentivirus model in which the deleterious function of the Nef accessory proteins could be demonstrated in lymphocytes without the complication of infection in the cells.
Materials and methods
Generation of CAEV/SIVsmm PBj 14 nef chimeric genome
The CAEV-nef genome was derived from the previously reported CAEV plasmid using a similar strategy that we recently reported (Villet et al., 2003b; Bouzar et al., 2003) . Briefly, the nef gene was amplified by PCR from the SIV PBj-14 proviral genome, using the following primers: 5′-TAA ACC CGG GGT GGG GAA CAT AAG GAC GCT GCA GAG AGC CCG TGA AGT C-3′ (NefPBj5′) and 5′-GCC AGC CTC TCC GCA GAG CGA CTG AAT-3′ (NefPBj3′), that are complementary to the beginning and end of nef gene, respectively. The Nef PBj5′ primer contains sequences that restore the end of the coding sequences of CAEV tat gene. The resulting 1084 bp PCR fragment was subcloned into the pGEM-t plasmid DNA (Promega, Charbonnieres, France) and then re-isolated from the pGEM-nef plasmid following double digestion with Sma1 and Spe1 endonucleases. The Spe1 extremity was transformed in blunt end following Klenow polymerase treatment, and the resulting product was inserted into the unique Sma-1 site located at the end of tat and upstream of env coding sequences of the genome of the infectious molecular clone CAEV. The resulting recombinant plasmid DNA that contained the nef gene in the orientation of CAEV transcription was named CAEV-nef.
Cells and viruses
GSM cells were used to produce virus stock and as indicator cells to quantify the infectivity and cytopathic effects (CPE) of viruses used in this study. CPE is characterized by development of foci of multinucleated giant cells. GSM cells were originally obtained from explanted carpal synovial membranes isolated from a colostrum-deprived newborn goat as previously described (Silva Teixeira et al., 1997) . These cells were shown to be highly susceptible to CAEV infection and development of CPE. The cell line was expanded by cultivation in minimum essential medium (MEM) supplemented with 10% fetal bovine serum (FBS, Invitrogen, Montpelier, France) and propagated by incubation at 37°C and 5% CO 2 with high humidity. To produce CAEV and CAEV-nef as virus stocks, 5 μg of each corresponding plasmid DNA was used to transfect GSM cells (5 × 10 5 cells/25 cm 2 flask) using the lipofectamine method (Silva Teixeira et al., 1997) . At 18 h post-transfection, the medium was removed and cell monolayers were washed three times with phosphate buffered saline (PBS) and then incubated in fresh medium. Culture medium of cells was collected on day 5 post-transfection, clarified by filtration through 0.45-μm membrane filters and used to inoculate fresh GSM cells in which virus stocks were prepared. Serial 10-fold dilutions of virus stocks were used to inoculate monolayers of the indicator GSM cells, and 6 days later cells were stained with May-Grünwald-Giemsa, and examined for the presence of CPE. Syncitia were scored and the titers were calculated using the Reed-Muench method and were expressed as tissue culture infectious dose (TCID50) per milliliter of virus stock. Virus stocks had approximately 1 × 10 7 TCID 50/ml . To compare the CPE induced by CAEV and CAEV-nef, semi confluent GSM cell cultures were inoculated at a multiplicity of infection (MOI) of 0.1 with each virus. Seven days later, cells were stained with May-Grünwald-Giemsa and observed for CPE. First we scored the number of nuclei per syncitium in 20 randomly selected syncitia to determine the mean number per cell. Second we scored the number of syncitia in 10 randomly selected fields to determine the mean number per field.
The expression of SIV Nef protein was detected by immunostaining in CAEV-nef-infected GSM cells cultured in eight chamber slides (Lab Tek). GSM cell monolayers were inoculated with CAEV and CAEV-nef at MOI of 0.1 and incubated at 37°C in 5% CO 2 . At 5 days post-infection cells were rinsed with PBS and fixed with acetone. SIV Nef protein expression was detected using a mouse-specific polyclonal antibody directed against SIVsmm PBj14 Nef. This serum was produced following DNA immunization of mice (3 injections of 50 μg each at 1-week intervals) with a plasmid DNA construct expressing the SIVsmm PBj14 nef gene under the transcriptional control of CMV promoter (data not shown). Cells were incubated 30 min at 37°C with the primary anti-Nef polyclonal antibody diluted (1/200) in PBS containing 1% BSA, PBS/ BSA, washed with PBS and then incubated for 30 min with a secondary rabbit anti-mouse biotinylated antibody (DAKO Kit, France) diluted (1/1000) in PBS/BSA. Cells were washed with PBS, incubated 30 min in PBS solution containing streptavidine-biotin-peroxidase complex and then incubated for 10 min in PBS solution supplemented with 1 mg/ml diaminobenzidine. The staining was stopped by washing with water and then darkened following short incubation in osmic acid. Cells were then counterstained with hematoxylin and mounted in aqueous mounting medium. Appropriate negative controls were included for the specificity of anti-Nef antibody.
For radioimmunoprecipitation (RIPA) analysis, cells were labeled with 35 S-methionine and cysteine and viral proteins were specifically immunoprecipaitated using a polyclonal serum anti-CAEV or anti-SIV Nef as previously described (Chebloune et al., 1996; Hegde et al., 2005) . Proteins were separated on SDS-PAGE and bands revealed by autoradiography using the standard methods.
Isolation of goat PBMCs and derivation of macrophages
Goat peripheral blood mononuclear cells, PBMCs, were isolated by density-gradient centrifugation of blood using the Ficoll method, as previously described . Briefly, 50 ml of blood collected by venipuncture in 2 mM EDTA was centrifuged at 400×g for 5 min at 20°C to separate the red blood cells from the plasma. Buffy coats were harvested and diluted three times in Hanks solution containing 2 mM EDTA. PBMCs were purified following centrifugation at 400 g for 45 min at 20°C through Ficoll-Hypaque gradients (Histopaque 1.077, Sigma, France). Two types of cells were derived from the PBMCs. First, to push monocytes to differentiate into macrophages, PBMCs were resuspended into 15 ml of medium consisting of RPMI 1640 (Invitrogen, Montpelier, France) supplemented with 10 mM HEPES buffer, 0.05 mM 2-β-mercapthoethanol, 2 mM glutamine, 0.05 mg/ml gentamicin and 20% heat inactivated lamb serum (Invitrogen, Montpelier, France) and were maintained in sterile polypropylene tubes at 37°C for 5-7 days where the monocytes differentiated into MDMs. Cells were then transferred to 6-well plates where the MDMs immediately established monolayers. One day later, the non-adherent cells were removed and the adherent MDMs rinsed twice with medium. MDM cultures were then incubated in 2 ml of fresh medium or inoculated with 2 ml of infectious medium containing 10 4 TCID 50 of CAEV-nef and CAEV at MOI = 0.1. Three days later, freshly isolated PBMCs from the same goat were resuspended in R10 consisting of RPMI 1640 (Invitrogen, Montpelier, France) supplemented with 10 mM HEPES buffer, 0.05 mM 2-β-mercapthoethanol, 2 mM glutamine, 0.05 mg/ml gentamicin and 10% of heat inactivated fetal bovine serum (FBS, Invitrogen, Montpelier, France) and human recombinant (Hr) IL-2 (0.25 IU/mL; Interchim). Two milliliters of medium containing 5 × 10 6 PBMCs was added to monolayers of MDM cultures, uninfected as well as MDMs infected with each of the two viruses.
Analysis of IL-2R expression as indicator of lymphocyte activation
To assess kinetics of expression of the interleukin 2 receptor (IL2-R) on the surfaces of activated lymphocytes, goat PBMCs cocultured with non-infected, CAEV and CAEV-nef-infected goat MDMs were harvested on different days following coculture and stained with anti-goat IL2-R monoclonal antibody (VMRD, La Jolla). The cells were transferred into 96-well round bottom tissue culture plates at a density of 0.5 × 10 6 per well. Cells were washed with PBS (centrifugation at 800×g, 2 min, 4°C) and then incubated, 30 min at 4°C, with the primary mouse monoclonal antibody directed against goat IL2-R (dilution: 1.5% in PBS/BSA, VMRD). After two rinses with PBS, cells were incubated 30 min at 4°C with a secondary FITC-conjugated anti-mouse antibody (SIGMAAldrich, la Verpillere, France) diluted in PBS/BSA. Cells were then rinsed and fixed in 1% paraformaldehyde. The samples were analyzed using LYSYS II software and a minimum of 10 5 cells in a Becton Dickinson Facscan instrument. Lymphocytes were gated according to forward-scatter versus side-scatter characteristics.
Proliferation assay of goat lymphocytes PBMC proliferation was evaluated by incorporation of BrdU into goat PBMCs from the cocultures with goat macrophages. As a positive control, a coculture of goat PBMCs with noninfected goat macrophages was treated with phytohemaglutinine (PHA, 2 μg/ml, SIGMA-Aldrich, la Verpillere France) for 3 days and human recombinant (Hr) IL-2 (0.25 IU/mL; Interchim). At different days post-coculture, samples of 0.5 × 10 6 cells were incubated for 1 h with 10 μM of 5-bromo-2′-deoxyuridine (BrdU) that allows the incorporation of BrdU into DNA in cells engaged in DNA synthesis. Cells were then rinsed twice with PBS and fixed for 1 h at + 4°C by addition of 50% ethanol (prechilled to − 20°C). Cells were then centrifuged for 10 min at 800×g. To depurinate chromosomal DNA, samples were treated with 2 N HCl for 30 min at room temperature. After several washing steps with PBS 0.5% Tween 20, the pH of the cell suspension was adjusted to 7.2 to 7.5. To detect cells that had entered the S phase, cells were incubated for 30 min at room temperature with FITC-conjugated mouse anti-BrdU monoclonal antibody (DAKO, Trappes, France). Cells were then rinsed twice with PBS 0.5% Tween 20, resuspended in PBS and then analyzed on a Becton Dickinson Facscan instrument equipped with LYSYS II software for a minimum of 10 5 cells by gating lymphocytes according to forward-scatter versus side-scatter characteristics.
Evaluation of apoptosis in goat lymphocytes
Samples of goat PBMCs were harvested and analyzed for DNA breaks using the Apostain mAb to ssDNA (F7-26) commercial kit (Alexis Biochemicals, France) according to the manufacturer's instructions. The Apostain test quantitates apoptosis at the single-cell level after DNA denaturation by heating at a low temperature in the presence of formamide and staining with a monoclonal antibody (Mab) F7-26 specific to single-stranded DNA (ssDNA). As positive controls, goat PBMCs were stimulated to undergo apoptosis by treatment with 20 μM of staurosporine (SIGMA-Aldrich, La Verpillere, France). PBMCs cocultured with non-infected MDMs were used for each experiment as negative controls. The percentages of apoptotic cells reported in the figure were defined as the proportion of cells containing fluorescein label in their DNA. Stained cells were acquired by flow cytometry and lymphocytes gated according to forward-scatter versus side-scatter characteristics were analyzed by the Lysis II analysis Software at a 488-nm argon ion laser.
PCR analysis
Goat MDMs inoculated with CAEV and CAEV-nef at MOI of 0.1 in 25 cm 2 tissue culture flasks (5 × 10 5 cells/flask), and 3 days later they were cocultured with fresh PBMCs (10 7 cells/ flask). At day 7 post-coculture DNA was isolated from cells in suspension and from macrophage monolayers (Quiagen, DNeasy Tissue Kit, France) and samples of these DNAs were used as templates for PCR analysis using two sets of oligonucleotide primers: 5′-GAT TAG GGC CTG TGG ATG CAG-3′ (tat) and 5′-CAG TTA AGC GCA TGT ATC TGG-3′) (env) specific to CAEV tat and env genes and 5′-CAT AAG GAC GCT GCA GAG AGC CCG TGA AGT C-3′ (NefPBj5′) and 5′-GCC AGC CTC TCC GCA GAG CGA CTG AAT-3′ (NefPBj3′) complementary to SIVsmm PBj14 nef coding sequences. The primers specific to tat and env sequences should generate an amplified fragment DNA containing 142 bp and 1226 bp from CAEV and CAEVpBSCAnef genomes, respectively. The primers specific to SIV nef coding sequences amplify a PCR product of 1084 bp from CAEVpBSCAnef genome only. Oligonucleotides primers ES30: 5′-TCA TGT TTG AGA CCT TCA ACA CCC CAG-3′ and ES32: 5′-CCA GGG GAA GGC TGG AAG AGT GCC-3′, that generate a PCR product of 393 bp specific to the fourth exon of β-actin gene were used as an internal control for cellular DNA detection.
PCR amplification was performed using the following parameters: initial DNA denaturation at 94°C for 5 min, followed by 35 cycles of denaturation at 92°for 1 min, annealing at 56°C for 1.5 min and primer extension at 70°C for 2.5 min; a final incubation for 15 min at 70°C was performed to terminate initiated DNA synthesis. After PCR amplification, 10 μl of aliquots from each sample was separated by electrophoresis on 1.5% agarose gel, and then DNA product was visualized by staining with ethidium bromide.
